Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine versus bisoprolol for attenuation of post-PCI microvascular dysfunction in stable angina
2015-003260-37Phase 4Unknown
- Sponsor
- Liverpool Heart and Chest Hospital
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine and bisoprolol in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Liverpool Heart and Chest Hospital. Primary endpoint: Index of Microvascular Resistance after PCI. Status: unknown.
02
Drugs
ivabradinebisoprolol
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on 2015-003260-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003260-37.